Mousa SA - Search Results

1

Retraction Note: Pharmacokinetics, Biodistribution, and Anti-Angiogenesis Efficacy of Diamino Propane Tetraiodothyroacetic Acid-conjugated Biodegradable Polymeric Nanoparticle.

Li W, Yalcin M, Bharali DJ, Lin Q, Godugu K, Fujioka K, Keating KA, Mousa SA. Li W, et al. Among authors: mousa sa. Sci Rep. 2023 Oct 3;13(1):16594. doi: 10.1038/s41598-023-43642-5. Sci Rep. 2023. PMID: 37789122 Free PMC article. No abstract available.

2

Micro- and nanoparticle-based vaccines for hepatitis B.

Bharali DJ, Mousa SA, Thanavala Y. Bharali DJ, et al. Among authors: mousa sa. Adv Exp Med Biol. 2007;601:415-21. doi: 10.1007/978-0-387-72005-0_44. Adv Exp Med Biol. 2007. PMID: 17713030 Review.

3

From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress.

Mousa SA, Bharali DJ, Armstrong D. Mousa SA, et al. Mol Biotechnol. 2007 Sep;37(1):72-80. doi: 10.1007/s12033-007-0064-7. Mol Biotechnol. 2007. PMID: 17914168 Review.

4

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.

Mousa SA, Bergh JJ, Dier E, Rebbaa A, O'Connor LJ, Yalcin M, Aljada A, Dyskin E, Davis FB, Lin HY, Davis PJ. Mousa SA, et al. Angiogenesis. 2008;11(2):183-90. doi: 10.1007/s10456-007-9088-7. Epub 2007 Dec 13. Angiogenesis. 2008. PMID: 18080776

5

Novel nanoparticles for the delivery of recombinant hepatitis B vaccine.

Bharali DJ, Pradhan V, Elkin G, Qi W, Hutson A, Mousa SA, Thanavala Y. Bharali DJ, et al. Among authors: mousa sa. Nanomedicine. 2008 Dec;4(4):311-7. doi: 10.1016/j.nano.2008.05.006. Epub 2008 Jul 18. Nanomedicine. 2008. PMID: 18640075

6

Emerging nanopharmaceuticals.

Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA. Bawarski WE, et al. Among authors: mousa sa. Nanomedicine. 2008 Dec;4(4):273-82. doi: 10.1016/j.nano.2008.06.002. Epub 2008 Jul 18. Nanomedicine. 2008. PMID: 18640076 Review.

7

Cancer detection and treatment: the role of nanomedicines.

LaRocque J, Bharali DJ, Mousa SA. LaRocque J, et al. Among authors: mousa sa. Mol Biotechnol. 2009 Jul;42(3):358-66. doi: 10.1007/s12033-009-9161-0. Epub 2009 Mar 17. Mol Biotechnol. 2009. PMID: 19291428 Review.

8

Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers.

Bharali DJ, Khalil M, Gurbuz M, Simone TM, Mousa SA. Bharali DJ, et al. Among authors: mousa sa. Int J Nanomedicine. 2009;4:1-7. Epub 2009 Apr 1. Int J Nanomedicine. 2009. PMID: 19421366 Free PMC article. Review.

9

Semisynthesis and pharmacological activities of Tetrac analogs: angiogenesis modulators.

Bridoux A, Cui H, Dyskin E, Yalcin M, Mousa SA. Bridoux A, et al. Among authors: mousa sa. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3259-63. doi: 10.1016/j.bmcl.2009.04.094. Epub 2009 Apr 24. Bioorg Med Chem Lett. 2009. PMID: 19427201

10

Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties.

Kemp MM, Kumar A, Mousa S, Dyskin E, Yalcin M, Ajayan P, Linhardt RJ, Mousa SA. Kemp MM, et al. Among authors: mousa s, mousa sa. Nanotechnology. 2009 Nov 11;20(45):455104. doi: 10.1088/0957-4484/20/45/455104. Epub 2009 Oct 13. Nanotechnology. 2009. PMID: 19822927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page